Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Trisomy and SF3B1[original query] |
|---|
| The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 2013 Jan 121 (3): 468-75. Oscier David G, Rose-Zerilli Matthew J J, Winkelmann Nils, Gonzalez de Castro David, Gomez Belen, Forster Jade, Parker Helen, Parker Anton, Gardiner Anne, Collins Andrew, Else Monica, Cross Nicholas C P, Catovsky Daniel, Strefford Jonathan |
| Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood 2013 Jun 121 (24): 4902-5. Rossi Davide, Spina Valeria, Bomben Riccardo, Rasi Silvia, Dal-Bo Michele, Bruscaggin Alessio, Rossi Francesca Maria, Monti Sara, Degan Massimo, Ciardullo Carmela, Serra Roberto, Zucchetto Antonella, Nomdedeu Josep, Bulian Pietro, Grossi Alberto, Zaja Francesco, Pozzato Gabriele, Laurenti Luca, Efremov Dimitar G, Di-Raimondo Francesco, Marasca Roberto, Forconi Francesco, Del Poeta Giovanni, Gaidano Gianluca, Gattei Valt |
| SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia 2014 Jan 28 (1): 108-17. Jeromin S, Weissmann S, Haferlach C, Dicker F, Bayer K, Grossmann V, Alpermann T, Roller A, Kohlmann A, Haferlach T, Kern W, Schnittger |
| Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia 2015 Feb 29 (2): 329-36. Baliakas P, Hadzidimitriou A, Sutton L-A, Rossi D, Minga E, Villamor N, Larrayoz M, Kminkova J, Agathangelidis A, Davis Z, Tausch E, Stalika E, Kantorova B, Mansouri L, Scarfò L, Cortese D, Navrkalova V, Rose-Zerilli M J J, Smedby K E, Juliusson G, Anagnostopoulos A, Makris A M, Navarro A, Delgado J, Oscier D, Belessi C, Stilgenbauer S, Ghia P, Pospisilova S, Gaidano G, Campo E, Strefford J C, Stamatopoulos K, Rosenquist R, |
| NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. Leukemia & lymphoma 2014 Dec 55 (12): 2785-92. Chiaretti Sabina, Marinelli Marilisa, Del Giudice Ilaria, Bonina Silvia, Piciocchi Alfonso, Messina Monica, Vignetti Marco, Rossi Davide, Di Maio Valeria, Mauro Francesca Romana, Guarini Anna, Gaidano Gianluca, Foà Rob |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
| Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia. Haematologica 2018 9 104 (2): 360-369. Baliakas Panagiotis, Moysiadis Theodoros, Hadzidimitriou Anastasia, Xochelli Aliki, Jeromin Sabine, Agathangelidis Andreas, Mattsson Mattias, Sutton Lesley-Ann, Minga Eva, Scarfò Lydia, Rossi Davide, Davis Zadie, Villamor Neus, Parker Helen, Kotaskova Jana, Stalika Evangelia, Plevova Karla, Mansouri Larry, Cortese Diego, Navarro Alba, Delgado Julio, Larrayoz Marta, Young Emma, Anagnostopoulos Achilles, Smedby Karin E, Juliusson Gunnar, Sheehy Oonagh, Catherwood Mark, Strefford Jonathan C, Stavroyianni Niki, Belessi Chrysoula, Pospisilova Sarka, Oscier David, Gaidano Gianluca, Campo Elias, Haferlach Claudia, Ghia Paolo, Rosenquist Richard, Stamatopoulos Kostas, |
| Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group. Genes, chromosomes & cancer 2018 Sep . Roos-Weil Damien, Nguyen-Khac Florence, Chevret Sylvie, Touzeau Cyrille, Roux Clémence, Lejeune Julie, Cosson Adrien, Mathis Stéphanie, Feugier Pierre, Leprêtre Stéphane, Béné Marie-Christine, Baron Marine, Raynaud Sophie, Struski Stéphanie, Eclache Virginie, Sutton Laurent, Lesty Claude, Merle-Béral Hélène, Cymbalista Florence, Ysebaert Loïc, Davi Frédéric, Leblond Véronique, |
| Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood 2019 9 134 (21): 1821-1831. Chapiro Elise, Pramil Elodie, Diop M'boyba, Roos-Weil Damien, Dillard Clémentine, Gabillaud Clémentine, Maloum Karim, Settegrana Catherine, Baseggio Lucile, Lesesve Jean-François, Yon Mélanie, Jondreville Ludovic, Lesty Claude, Davi Frédéric, Le Garff-Tavernier Magali, Droin Nathalie, Dessen Philippe, Algrin Caroline, Leblond Véronique, Gabarre Jean, Bouzy Simon, Eclache Virginie, Gaillard Baptiste, Callet-Bauchu Evelyne, Muller Marc, Lefebvre Christine, Nadal Nathalie, Ittel Antoine, Struski Stéphanie, Collonge-Rame Marie-Agnès, Quilichini Benoit, Fert-Ferrer Sandra, Auger Nathalie, Radford-Weiss Isabelle, Wagner Lena, Scheinost Sebastian, Zenz Thorsten, Susin Santos A, Bernard Olivier A, Nguyen-Khac Florence, , |
| Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia. British journal of haematology 2019 6 187 (1): 82-92. Huang Ying-Jung, Kuo Ming-Chung, Chang Hung, Wang Po-Nan, Wu Jin-Hou, Huang Yen-Min, Ma Ming-Chun, Tang Tzung-Chih, Kuo Ching-Yuan, Shih Lee-Yu |
| Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. Leukemia research 2019 Apr 81 75-81. Spunarova Michaela, Tom Nikola, Pavlova Sarka, Mraz Marek, Brychtova Yvona, Doubek Michael, Panovska Anna, Skuhrova Francova Hana, Brzobohata Anna, Pospisilova Sarka, Mayer Jiri, Trbusek Mart |
| DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains. Experimental hematology 2019 2 72 9-13. Hernández-Sánchez María, Rodríguez-Vicente Ana Eugenia, González-Gascón Y Marín Isabel, Quijada-Álamo Miguel, Hernández-Sánchez Jesús María, Martín-Izquierdo Marta, Hernández-Rivas José Ángel, Benito Rocío, Hernández-Rivas Jesús Mar |
| Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression. Blood research 2020 8 55 (3): 131-138. Srinivasan Vishrut K, Naseem Shano, Varma Neelam, Lad Deepesh P, Malhotra Pank |
| SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes. Clinical lymphoma, myeloma & leukemia 2020 3 20 (6): 400-406.e2. Zhang Qing, Haider Mintallah, Al Ali Najla H, Lancet Jeffrey E, Epling-Burnette Pearlie K, List Alan F, Padron Eric, Komrokji Rami |
| Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leukemia research 2022 4 116 106827. Jelloul Fatima Zahra, Yang Richard, Garces Sofia, Kanagal-Shamanna Rashmi, Ok Chi Y, Loghavi Sanam, Routbort Mark J, Zuo Zhuang, Yin C Cameron, Floyd Kristen, Bassett Roland L, Wierda William, Jain Nitin, Thompson Philip, Luthra Rajyalakshmi, Medeiros L Jeffrey, Patel Keyur |
| Copy Number Variations and Gene Mutations Identified by Multiplex Ligation-Dependent Probe Amplification in Romanian Chronic Lymphocytic Leukemia Patients. Journal of personalized medicine 2023 8 13 (8): . Beata Balla, Florin Tripon, Marcela Candea, Claudia Banes |
| Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
| MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
- Page last reviewed:Feb 1, 2024
- Content source: